Trial Profile
First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension: A Safety and Efficacy Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2018
Price :
$35
*
At a glance
- Drugs Bosentan (Primary) ; Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 08 Dec 2015 New trial record